IGF1R and Ewing sarcoma: It was reported that the IGF-1R pathway is activated in several cancers, such as hepatocellular carcinoma [73], pancreatic ductal carcinoma [74], retinoblastoma [75], colorectal cancer [76], and Ewing sarcoma [77,78].